Literature DB >> 4371539

Distribution of WR-2721 in normal and malignant tissues of mice and rats bearing solid tumors: dependence on tumor type, drug dose and species.

L C Washburn, J E Carlton, R L Hayes.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4371539

Source DB:  PubMed          Journal:  Radiat Res        ISSN: 0033-7587            Impact factor:   2.841


× No keyword cloud information.
  6 in total

1.  Effects of amifostine on cisplatin induced DNA adduct formation and toxicity in malignant glioma and normal tissues in rat.

Authors:  P Bergström; A Johnsson; T Bergenheim; R Henriksson
Journal:  J Neurooncol       Date:  1999-03       Impact factor: 4.130

2.  Salivary gland protection by amifostine in high-dose radioiodine therapy of differentiated thyroid cancer.

Authors:  K H Bohuslavizki; S Klutmann; C Bleckmann; W Brenner; S Lassmann; J Mester; E Henze; M Clausen
Journal:  Strahlenther Onkol       Date:  1999-02       Impact factor: 3.621

Review 3.  Amifostine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential as a radioprotector and cytotoxic chemoprotector.

Authors:  C M Spencer; K L Goa
Journal:  Drugs       Date:  1995-12       Impact factor: 9.546

4.  A more general role for WR-2721 in cancer therapy.

Authors:  J M Yuhas
Journal:  Br J Cancer       Date:  1980-05       Impact factor: 7.640

5.  Effect of amifostine, a radiation-protecting drug, on oxygen concentration in tissue measured by EPR oximetry and imaging.

Authors:  Megumi Ueno; Shingo Matsumoto; Atsuko Matsumoto; Sushma Manda; Ikuo Nakanishi; Ken-Ichiro Matsumoto; James B Mitchell; Murali C Krishna; Kazunori Anzai
Journal:  J Clin Biochem Nutr       Date:  2017-03-25       Impact factor: 3.114

6.  Treatment of tumours with the combination of WR-2721 and cis-dichlorodiammineplatinum (II) or cyclophosphamide.

Authors:  J M Yuhas; J M Spellman; S W Jordan; M C Pardini; S M Afzal; F Culo
Journal:  Br J Cancer       Date:  1980-10       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.